SCHEMBL6672328

SCHEMBL6672328

CN(C)CCOC(Cl)c1ccc(Cc2nccn2C)cc1C(Cl)OCCN(C)C

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM5 Q9NZQ8 1/20 0.32
HRH3 Q9Y5N1 2/20 0.32
LMNA P02545 1/20 0.32
CHRM2 P08172 1/20 0.32
ADRA2B P18089 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
HRH1 P35367 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KCNH2 Q12809 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
HTR1A P08908 2/20 0.30
HTR2C P28335 1/20 0.30
LTA4H P09960 1/20 0.30
CXCR4 P61073 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6650132 0.94 HRH3 (0.33) TRPM5HRH3CHRM2SLC6A2SLC6A4
SCHEMBL6650451 0.86 LMNA (0.39) TRPM5HRH3LMNACHRM2ADRA2B
SCHEMBL6649435 0.83 OPRK1 (0.37) HRH3LMNACHRM2ADRA2BSLC6A2
SCHEMBL6654163 0.80 HRH3 (0.35) HRH3LMNACHRM2ADRA2BSLC6A2
SCHEMBL6649371 0.79 HTR1A (0.32) TRPM5LMNACHRNB2CHRNA4HTR1A
SCHEMBL6651103 0.78 OPRK1 (0.36) HRH3LMNACHRM2SLC6A2SLC6A4
SCHEMBL6648700 0.76 HRH3 (0.35) HRH3CHRM2SLC6A2SLC6A4HRH1
SCHEMBL6651872 0.76 LMNA (0.36) TRPM5HRH3LMNACHRM2ADRA2B
SCHEMBL6654437 0.76 HRH1 (0.38) HRH3LMNACHRM2SLC6A2SLC6A4
SCHEMBL6650490 0.74 MEN1 (0.37) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed